To establish the Commission on Strengthening the Domestic Pharmaceutical Supply Chain, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To establish the Commission on Strengthening the Domestic Pharmaceutical Supply Chain, and for other purposes., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Trade, Defense.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H84A95BBB12E04429A03435A9208212B0: 1. Short title This Act may be cited as the Pharmaceutical Security Production Act.
- Section H0262C8428A3A4E3F87F963111D968078: 2. Commission on Strengthening the Domestic Pharmaceutical Supply Chain There is established a commission to be known as the Commission on Strengthening the...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To establish the Commission on Strengthening the Domestic Pharmaceutical Supply Chain, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Trade, Defense
Primary Purpose
This bill, To establish the Commission on Strengthening the Domestic Pharmaceutical Supply Chain, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Legislative Progress
IntroducedMr. Torres of New York introduced the following bill; which …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_commission"
- → The commission identified in the operative section
- "secretary_of_defense"
- → Secretary of Defense
- "secretary_of_commerce"
- → Secretary of Commerce
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology